moxalactam has been researched along with Klebsiella Infections in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Du, X; Hu, H; Hua, X; Jiang, Y; McNally, A; Shi, Q; Sun, L; Wu, X; Yu, Y; Zhang, P | 1 |
| Denson, S; Kaplan, SL; Mason, EO; Pickering, LK; Ramos, OM | 1 |
| Dusehu, E; Lallement, PY; Philippe, JM; Veyssier, P | 1 |
| Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
| Cherubin, CC; Cleri, D; Corrado, ML; Gombert, M; Landesman, SH | 1 |
| McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N | 1 |
| Goldstein, E; Hoeprich, PD; Nolan, SM; Olson, DA | 1 |
| Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS | 1 |
| Arakawa, Y; Horii, T; Ichiyama, S; Kato, N; Ohta, M; Wacharotayankun, R | 1 |
| Cassady, G; Knight, P | 1 |
| Cherubin, CE; Eng, RH | 1 |
12 other study(ies) available for moxalactam and Klebsiella Infections
| Article | Year |
|---|---|
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Cefiderocol; Ceftazidime; Drug Combinations; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Moxalactam | 2023 |
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Citrobacter; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Moxalactam | 1982 |
[Levels of moxalactam in the cerebral ventricles during the treatment of Klebsiella septicemia].
Topics: Cephalosporins; Cephamycins; Cerebral Ventricles; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxalactam; Sepsis | 1983 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
Topics: Aged; Blood-Brain Barrier; Cephalosporins; Cephamycins; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Male; Meningitis; Middle Aged; Moxalactam | 1980 |
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens | 1981 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Adult; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Middle Aged; Moxalactam | 1981 |
Moxalactam therapy for bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1981 |
Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cloning, Molecular; Drug Resistance, Microbial; Genes, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Moxalactam; Plasmids | 1993 |
Control of infection due to Klebsiella pneumoniae in an intensive care nursery.
Topics: Alabama; Cephalexin; Cohort Studies; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Moxalactam; Nurseries, Hospital; Nursing Staff, Hospital; Serotyping | 1990 |
Experience with the use of cefotaxime in the treatment of bacterial meningitis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1986 |